To further investigate the effects of BR2 on therapeutic protein delivery into cancer cells, Tat and BR2 were each fused with anti-Ras scFv (Fig. 4A), and the intracellular penetration of these fusions was assessed by Western blotting. This evidence concerns the gene TAT and cancer.